Abstract
Because there is evidence for an active immunologic response against sarcoma, a clinical trial of adjuvant immunotherapy using bacillus Calmette-Guérin (BCG) and tumor cell vaccine was begun. Eleven of 18 patients with localized soft tissue sarcoma who received immunotherapy are free of disease, compared to only 5 of 15 treated by operation alone who are free of disease. Furthermore, immunotherapy also prolonged the median disease-free interval from 7.3 months to 15 months in the patients who experienced recurrence of their disease.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 2187-2189 |
| Number of pages | 3 |
| Journal | JAMA: The Journal of the American Medical Association |
| Volume | 236 |
| Issue number | 19 |
| DOIs | |
| State | Published - Nov 8 1976 |
| Externally published | Yes |
ASJC Scopus subject areas
- General Medicine
Fingerprint
Dive into the research topics of 'Skeletal and Soft Tissue Sarcomas: Treatment With Adjuvant Immunotherapy'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS